Pancreatic Cancer Research

ResearcherDartmouth CollegeNo recent work listed

Stuart R. Gordon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8824-0492; OpenAlex author ID A5110428231. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2011: 3 papers · 2012: 1 paper · 2013: 2 papers · 2014: 2 papers · 2015: none · 2016: 2 papers

Papers 10

  1. Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled … Last author DOI 10.1016/j.gie.2016.02.047↗
  2. Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and f… Co-author DOI 10.18632/oncotarget.7718↗
  3. A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer. Co-author DOI 10.1016/j.cgh.2014.02.038↗
  4. The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus. Co-author DOI 10.1097/mpa.0000000000000162↗
  5. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Co-author DOI 10.1016/j.cancergen.2013.05.020↗
  6. Successful retreatment with chemoradiotherapy for local recurrence of pancreatic adenocarcinoma after neoadjuvant therapy and pancreaticoduodenectomy. Co-author PMID 24147160↗
  7. Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. Co-author DOI 10.1093/annonc/mds109↗
  8. Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study. First author DOI 10.1016/j.gie.2011.03.1235↗
  9. The impact of prior biliary stenting on the accuracy and complication rate of endoscopic ultrasound fine-needle aspiration for diagnosing pancreatic adenocarci… First author DOI 10.1097/mpa.0b013e3181f66e64↗
  10. MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-11-0695↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Timothy B. Gardner · 8 shared papers, 2011–2016 · strength 0.29
  2. Gregory J. Tsongalis · 6 shared papers, 2012–2016 · strength 0.21
  3. Arief Antonius Suriawinata · 6 shared papers, 2012–2016 · strength 0.21
  4. Richard J. Barth · 5 shared papers, 2012–2016 · strength 0.19
  5. J. Marc Pipas · 6 shared papers, 2011–2014 · strength 0.19
  6. Kerrington D. Smith · 4 shared papers, 2012–2016 · strength 0.16
  7. Bassem I. Zaki · 4 shared papers, 2012–2016 · strength 0.15
  8. Meir Preis · 2 shared papers, 2011–2012 · strength 0.05
  9. Murray Korc · 2 shared papers, 2011–2012 · strength 0.05
  10. Jessica M. Fisher · 1 shared paper, 2011 · strength 0.04
  11. Francine Blumental De Abreu · 1 shared paper, 2016 · strength 0.04
  12. Craig R. Tomlinson · 1 shared paper, 2016 · strength 0.04
  13. Robert J. Allaway · 1 shared paper, 2016 · strength 0.04
  14. Minda A Gowarty · 1 shared paper, 2013 · strength 0.04
  15. Yue Xue · 1 shared paper, 2013 · strength 0.04
  16. Kabir Mody · 1 shared paper, 2014 · strength 0.04
  17. Anna E. Szafranska-Schwarzbach · 1 shared paper, 2014 · strength 0.03
  18. Shivakumar Vignesh · 1 shared paper, 2014 · strength 0.03
  19. Bernard F. Andruss · 1 shared paper, 2014 · strength 0.03
  20. Johanna B. Munding · 1 shared paper, 2014 · strength 0.03
  21. Andrea Tannapfel · 1 shared paper, 2014 · strength 0.03
  22. Darwin Lewis Conwell · 1 shared paper, 2014 · strength 0.03
  23. Anna Wiechowska–Kozłowska · 1 shared paper, 2014 · strength 0.03
  24. Stephan A. Hahn · 1 shared paper, 2014 · strength 0.03
  25. Barbara Ann Centeno · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.